|
⚲
|
| Keyboard |
| Anderman Jonathan
✚
|
|
|---|---|
| CIK # | 0002032625 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002032625] | |
| 4 | [0002032625] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Compass Therapeutics Inc | |
| Anderman Jonathan |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Compass Therapeutics Inc CMPX
Common Stock
|
2026-01-02 | Grant | 150,000 | $5.17 | 775,500 |
|
Compass Therapeutics Inc CMPX
Stock Option (Right to Buy) · derivative
|
2026-01-02 | Grant | 720,000 | $0.00 | |
|
Compass Therapeutics Inc CMPX
Common Stock
|
2025-04-07 | Buy | 20,000 | $1.54 | 30,800 |
|
Compass Therapeutics Inc CMPX
Stock Option (Right to Buy) · derivative
|
2025-02-11 | Grant | 280,000 | $0.00 | |
|
Compass Therapeutics Inc CMPX
Stock Option (Right to Buy) · derivative
|
2024-08-13 | Grant | 300,000 | $0.00 |